Literature DB >> 9348593

Decision making by parents and healthcare professionals when considering continued care for pediatric patients with cancer.

P S Hinds1, L Oakes, W Furman, P Foppiano, M S Olson, A Quargnenti, J Gattuso, B Powell, D K Srivastava, D Jayawardene, J T Sandlund, C Strong.   

Abstract

PURPOSE/
OBJECTIVES: To better define the treatment-related decisions considered most difficult by parents of pediatric patients with cancer and the factors that influenced their final decisions.
DESIGN: Retrospective-descriptive design.
SETTING: Pediatric oncology institution in the mid-southern region on the United States. SAMPLE: 39 parents representing 37 of 83 eligible families, 16 attending physicians, three nurses, and two chaplains.
METHODS: Parent participants responded by telephone to six open-ended interview questions and a 15-item questionnaire about factors that were important when making the decision to continue care. Healthcare professionals were interviewed face-to-face. MAIN RESEARCH VARIABLES: Most difficult treatment-related decisions; factors influencing decision making.
FINDINGS: Parents reported 15 types of difficult decisions, the majority of which were made late in the course of treatment. Deciding between a phase I drug study or no further treatment (n = 14), maintaining or withdrawing life support (n = 11), and giving more chemotherapy or giving no further treatment (n = 8) were the most frequently reported difficult decisions. Parents rated "recommendations received from healthcare professionals" as the questionnaire factor most important in their decision making, and healthcare professionals rated "discussion with the family of the patient" as the most important factor.
CONCLUSION: Parents of children or adolescents with cancer and their healthcare providers face difficult treatment-related decisions, many of which occur late in the course of treatment. Parents and healthcare professionals cite similar factors in their decision making but differ in their ratings of the factors' importance. For parents, the information and recommendations they receive from healthcare professionals figure most frequently and most importantly in their decision making. For healthcare professionals, the certainty that the patient will not get better and discussions with the patient's family figure most importantly in their decision making. Once parents conclude that their child can not get better, they are more likely to choose noncurative options such as choosing no further treatment or withdrawing life support. IMPLICATIONS FOR NURSING PRACTICE: Nurses can help determine what information parents need in their decision making. Particular attention must be given to ways to communicate the likelihood of the their child's survival.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9348593

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  22 in total

1.  Chemotherapy versus supportive care alone in pediatric palliative care for cancer: comparing the preferences of parents and health care professionals.

Authors:  Deborah Tomlinson; Ute Bartels; Janet Gammon; Pamela S Hinds; Jocelyne Volpe; Eric Bouffet; Dean A Regier; Sylvain Baruchel; Mark Greenberg; Maru Barrera; Hilary Llewellyn-Thomas; Lillian Sung
Journal:  CMAJ       Date:  2011-10-17       Impact factor: 8.262

2.  Changes in medical care at a pediatric oncology referral center after placement of a do-not-resuscitate order.

Authors:  Justin N Baker; Javier R Kane; Shesh Rai; Scott C Howard; Pamela S Hinds
Journal:  J Palliat Med       Date:  2010-10-30       Impact factor: 2.947

3.  Race does not influence do-not-resuscitate status or the number or timing of end-of-life care discussions at a pediatric oncology referral center.

Authors:  Justin N Baker; Shesh Rai; Wei Liu; Kumar Srivastava; Javier R Kane; Christine A Zawistowski; Elizabeth A Burghen; Jami S Gattuso; Nancy West; Jennifer Althoff; Adam Funk; Pamela S Hinds
Journal:  J Palliat Med       Date:  2009-01       Impact factor: 2.947

4.  Parent-clinician communication intervention during end-of-life decision making for children with incurable cancer.

Authors:  Pamela S Hinds; Linda L Oakes; Judy Hicks; Brent Powell; Deo Kumar Srivastava; Justin N Baker; Sheri L Spunt; Nancy K West; Wayne L Furman
Journal:  J Palliat Med       Date:  2012-06-26       Impact factor: 2.947

5.  Physician and nurse beliefs of phase 1 trials in pediatric oncology.

Authors:  Margaux J Barnes; Joseph Pressey; Julia Adams; Molly A Hensler; Avi Madan-Swain
Journal:  Cancer Nurs       Date:  2014 Sep-Oct       Impact factor: 2.592

Review 6.  What is known about parents' treatment decisions? A narrative review of pediatric decision making.

Authors:  Ellen A Lipstein; William B Brinkman; Maria T Britto
Journal:  Med Decis Making       Date:  2011-10-03       Impact factor: 2.583

7.  Patient involvement in informed consent for pediatric phase I cancer research.

Authors:  Victoria A Miller; Justin N Baker; Angela C Leek; Dennis Drotar; Eric Kodish
Journal:  J Pediatr Hematol Oncol       Date:  2014-11       Impact factor: 1.289

8.  Characteristics Associated With Preferences for Parent-Centered Decision Making in Neonatal Intensive Care.

Authors:  Elliott Mark Weiss; Dawei Xie; Noah Cook; Katherine Coughlin; Steven Joffe
Journal:  JAMA Pediatr       Date:  2018-05-01       Impact factor: 16.193

9.  Parental experience at the end-of-life in children with cancer: 'preservation' and 'letting go' in relation to loss.

Authors:  Marijke C Kars; Mieke H F Grypdonck; Maria C de Korte-Verhoef; Willem A Kamps; Esther M M Meijer-van den Bergh; Marian A Verkerk; Johannes J M van Delden
Journal:  Support Care Cancer       Date:  2009-12-03       Impact factor: 3.603

10.  Parents' views of cancer-directed therapy for children with no realistic chance for cure.

Authors:  Jennifer W Mack; Steven Joffe; Joanne M Hilden; Jan Watterson; Caron Moore; Jane C Weeks; Joanne Wolfe
Journal:  J Clin Oncol       Date:  2008-09-08       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.